Pulmonary tuberculosis was defined by exhibited chronic cough more than 2 weeks with or without hemoptysis,
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: The patients 18 years of age or older who newly diagnosed PTB and agreement to participate in the study will eligible for enrollment.
Exclusion criteria
Exclusion criteria: We will exclude the patients who are pregnant or breastfeeding, known hypersensitivity to NAC, HIV positive, history of massive hemoptysis (NAC may exacerbate severity of hemoptysis), estimating glomerular filtration rate less than 30 mL/min/1.73 m 2 , moribund state, history of porphyria, pre-existing liver disease, known rifampicin and/or multidrug resistance tuberculosis and earlier anti-tuberculosis treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| efficacy of NAC for sputum smear conversion in pulmonary tuberculosis end of 2 weeks, 4 weeks and 8 weeks after treatment event rate,adverse events along period of study event rate ,hospital admission, along period of study event rate ,needed mechanical ventilator, along period of study event rate ,acquired drug resistant regimen, along period of study event rate | — |
Secondary
| Measure | Time frame |
|---|---|
| adverse events along period of study event rate ,hospital admission along period of study event rate ,needed mechanical ventilator along period of study event rate ,acquired drug resistant regimen along period of study event rate | — |
Countries
Thailand
Contacts
Khon Kaen Hospital